Amlodipine/Olmesartan Medoxomil (Normetec) is contraindicated in patients who are hypersensitive to any component of the tablet or to dihydropyridine derivatives.
Amlodipine/Olmesartan Medoxomil (Normetec) is contraindicated in patients who become pregnant. When pregnancy is detected, Amlodipine/Olmesartan Medoxomil (Normetec) should be discontinued as soon as possible (see Use in Pregnancy & Lactation).
Do not co-administer aliskiren with Amlodipine/Olmesartan Medoxomil (Normetec) in patients with diabetes (see Interactions).